Loading…
Loading…
Editorial note: Market figures cited in this article are estimates based on publicly available industry reports and may vary by source. HalalExpo.com aims to present the most current data available but readers should verify figures for business decisions. Sources include the State of the Global Islamic Economy Report, DinarStandard, and national halal authority publications.
Vaccines are among the most important public health interventions in human history, having eradicated smallpox, nearly eliminated polio, and dramatically reduced the burden of dozens of infectious diseases. For the world's 1.9 billion Muslims, however, the question of whether vaccines are halal (permissible under Islamic law) is not merely academic. It touches on deeply held religious convictions about bodily purity, the prohibition on consuming or using porcine-derived substances, and the broader obligation to protect health and life.
The halal concern with vaccines stems primarily from the manufacturing process rather than the final product itself. Several components used in vaccine production raise questions for Muslim consumers and scholars alike. Understanding these concerns requires a basic grasp of how vaccines are made and which ingredients may be problematic.
Gelatin is the most commonly cited halal concern in vaccines. It is used as a stabiliser in several widely administered vaccines, helping to protect the active viral or bacterial components from degradation during storage and transport. Gelatin used in pharmaceutical manufacturing is predominantly derived from porcine (pig) sources because it is abundant, cost-effective, and has well-established safety and performance profiles.
Vaccines that have historically contained porcine gelatin include the measles-mumps-rubella (MMR) vaccine, the varicella (chickenpox) vaccine, certain influenza vaccines, and some formulations of the yellow fever vaccine. The amount of gelatin in each dose is small — typically measured in milligrams — but its presence is sufficient to raise questions about permissibility under Islamic dietary and purity laws.
Some vaccines are produced using cell lines derived from human foetal tissue obtained decades ago. The two most commonly used are WI-38 (derived in 1961) and MRC-5 (derived in 1966). These cell lines are used to grow viruses in laboratory conditions before they are harvested, purified, and formulated into vaccines. The rubella component of the MMR vaccine, the varicella vaccine, and the hepatitis A vaccine are among those produced using these cell lines.
While no foetal tissue is present in the final vaccine, the historical origin of these cell lines raises ethical and religious questions. Some scholars and Muslim communities have expressed concerns about the moral permissibility of benefiting from a process that originated with the use of aborted foetal tissue, even if the original tissue was obtained under circumstances that may have been medically indicated.
Ethanol and other alcohols are sometimes used as solvents, preservatives, or during the purification stages of vaccine production. While the final vaccine product contains negligible or no detectable alcohol, the use of alcohol during manufacturing has been questioned by some scholars who hold strict views on any contact with intoxicating substances.
Islamic scholarship has engaged seriously and substantively with the question of vaccine permissibility. The major opinions can be broadly categorised, though it is important to note that there is significant nuance within each position and that individual scholars may hold views that do not fit neatly into any single category.
The overwhelming majority of contemporary Islamic scholars, juristic councils, and fatwa bodies have ruled that vaccination is permissible and, in many cases, recommended or even obligatory. This position rests on several foundational principles of Islamic jurisprudence.
The principle of darurah (necessity) permits the use of otherwise prohibited substances when there is a genuine need to protect life and health and no viable halal alternative exists. Preventing serious illness and death through vaccination is considered a clear case of necessity by most scholars. The principle of istihalah (transformation) holds that when a substance undergoes a complete chemical transformation, it may lose its original ruling. Scholars who apply this principle to vaccine gelatin argue that the extensive chemical processing transforms the porcine gelatin into a fundamentally different substance that no longer carries the ruling of impurity.
The Islamic Fiqh Academy (IIFA), affiliated with the Organisation of Islamic Cooperation (OIC), has addressed vaccines on multiple occasions. In its resolutions, the Academy has affirmed that vaccines containing porcine-derived gelatin are permissible when no halal alternative is available, citing the principles of necessity and transformation. This position carries significant weight given the IIFA's stature as one of the most authoritative collective juristic bodies in the Sunni Muslim world.
The Islamic Medical Association of North America (IMANA) has taken a pragmatic position that balances religious principles with public health imperatives. Their bioethics committee has stated that Muslims should seek halal-certified vaccines when available but should not refuse vaccination when the only available option contains potentially problematic ingredients. The protection of life and community health takes precedence under the principle of necessity.
Several national fatwa councils have issued specific rulings on vaccines. Malaysia's National Fatwa Council has ruled that vaccines containing porcine derivatives are permissible under the principle of necessity when no halal alternative exists. Indonesia's Majelis Ulama Indonesia (MUI) has engaged extensively with vaccine manufacturers and has certified specific vaccines as halal while also ruling that non-halal-certified vaccines remain permissible when halal alternatives are unavailable. The MUI's engagement with vaccine producers has been particularly influential in driving the development of halal vaccine alternatives.
The UAE Fatwa Council, Egypt's Dar al-Ifta, and the Saudi Council of Senior Scholars have all issued similar rulings affirming vaccine permissibility. For a comprehensive list of halal certification bodies and their positions, see our certifier directory.
A smaller number of scholars, while not outright prohibiting vaccines, have expressed a strong preference for halal-certified alternatives and have encouraged the Muslim community and pharmaceutical industry to develop porcine-free vaccines. This position does not reject vaccination but advocates for consumer choice and industry responsiveness to religious dietary requirements. Some scholars in this camp argue that the principle of necessity should not be invoked casually when the pharmaceutical industry has the technical capability to produce gelatin-free or halal-gelatin vaccines but has chosen not to do so for commercial reasons.
The demand for halal vaccines has driven meaningful progress in the development and certification of alternatives. Several vaccine manufacturers have responded to market demand — particularly from Muslim-majority countries — by developing formulations that avoid porcine-derived ingredients entirely or by seeking halal certification for existing products.
Japan has led the way in developing gelatin-free vaccines. The Takeda Pharmaceutical Company produces a measles-rubella (MR) vaccine that does not contain gelatin, and Japan's national immunisation programme transitioned away from gelatin-containing vaccines in the late 1990s following reports of allergic reactions. This demonstrates that gelatin-free production is technically feasible and commercially viable.
Several meningococcal vaccines have received halal certification from recognised bodies. Saudi Arabia's requirement for Hajj pilgrims to be vaccinated against meningitis has created a strong market incentive for halal-certified meningococcal vaccines, and manufacturers including Sanofi Pasteur and Pfizer have obtained halal certification for specific products intended for this market.
Bio Farma, Indonesia's state-owned pharmaceutical company, has emerged as a global leader in halal vaccine production. Working closely with the MUI, Bio Farma has developed production processes for several vaccines that avoid porcine-derived ingredients entirely. Their halal-certified vaccines include formulations for polio, measles, and diphtheria-tetanus-pertussis (DTP). Bio Farma supplies vaccines not only to Indonesia but also exports to over 140 countries, many of them with significant Muslim populations.
The COVID-19 pandemic brought the halal vaccine question into sharp global focus. With billions of doses needed urgently and multiple vaccine platforms being deployed simultaneously, Islamic scholars and certification bodies moved quickly to address permissibility concerns.
The mRNA vaccines developed by Pfizer-BioNTech and Moderna were among the first to receive broad endorsement from Islamic scholars because their production process does not use porcine gelatin or animal-derived cell lines. The mRNA platform uses synthetic messenger RNA encapsulated in lipid nanoparticles, none of which are derived from animal sources. The MUI in Indonesia certified the Pfizer-BioNTech vaccine as halal, and similar endorsements came from fatwa bodies in Malaysia, the UAE, Saudi Arabia, and numerous other countries.
The AstraZeneca vaccine, which uses a modified chimpanzee adenovirus vector, raised more complex questions because its production involves the HEK 293 cell line, which was originally derived from human embryonic kidney cells in the 1970s. The MUI initially declared the AstraZeneca vaccine "haram but permissible" under necessity — a nuanced ruling that acknowledged the problematic ingredient origin while affirming that Muslims could and should receive the vaccine when no halal alternative was available. This dual classification generated significant public discussion but ultimately supported vaccination uptake.
China's Sinovac and Sinopharm vaccines, which use traditional inactivated virus technology, received halal certification from the UAE's authority and endorsement from several other bodies. However, the MUI declined to certify Sinovac as halal, instead ruling it permissible under necessity, citing concerns about certain production inputs. This divergence between certification bodies illustrates the complexity of halal vaccine assessment.
Halal vaccine policies and availability vary significantly by country, shaped by local fatwa rulings, procurement decisions, and regulatory frameworks.
Malaysia has one of the most developed frameworks for halal pharmaceuticals. The Department of Islamic Development Malaysia (JAKIM) provides halal certification for pharmaceutical products, and the government has actively promoted the development of a halal pharmaceutical industry as part of its economic development strategy. Malaysian healthcare providers generally offer information about vaccine ingredients to Muslim patients and, where possible, provide halal-certified alternatives.
Indonesia, the world's most populous Muslim-majority country, has the most rigorous halal vaccine certification process through the MUI. The government's national immunisation programme has increasingly prioritised halal-certified vaccines, and Bio Farma's domestic production capacity ensures that halal options are available for several routine childhood vaccines. The Halal Product Assurance Act of 2014 will eventually require halal certification for all pharmaceutical products, further driving industry development. For more on halal pharmaceutical standards and challenges, see our article on halal pharmaceuticals standards and challenges.
GCC countries generally follow the rulings of their respective national fatwa councils, which have broadly endorsed vaccination. Saudi Arabia's mandatory meningococcal vaccination for Hajj pilgrims has created a precedent for halal vaccine procurement, and the kingdom's healthcare system actively sources halal-certified vaccines where available. The UAE has been particularly proactive in halal pharmaceutical certification through its Emirates Authority for Standardisation and Metrology (ESMA).
In the United Kingdom, United States, Canada, and European Union countries, halal-certified vaccine alternatives are generally not available through routine healthcare programmes. Muslim communities in these countries typically follow the guidance of local Islamic organisations, most of which have endorsed vaccination based on the rulings of major international fatwa bodies. The UK's National Health Service (NHS) provides ingredient information for all vaccines in its programme, enabling Muslim patients to make informed decisions.
Navigating vaccine decisions as a Muslim involves balancing religious obligations with health protection. The following practical steps can help individuals and families make informed choices.
Healthcare providers are generally able to provide package inserts that list vaccine ingredients. Asking about specific components — gelatin, cell lines used in production, and alcohol — enables you to assess each vaccine against your own scholarly guidance. In many countries, patient information leaflets are available online through government health agencies.
While international fatwa bodies provide important guidance, your local imam or scholar can help you apply these rulings to your specific situation. Bring the ingredient information to the consultation so that the scholar can make an informed assessment. Most contemporary scholars will affirm the permissibility of vaccination even when halal alternatives are unavailable.
If a halal-certified or gelatin-free version of a vaccine exists, you are within your rights to request it. However, do not delay vaccination while waiting for an alternative that may not become available. The scholarly consensus is clear that protecting health and life takes precedence, and delaying vaccination exposes both the individual and the community to unnecessary risk.
The halal vaccine landscape is evolving rapidly. New production technologies, including plant-based vaccine platforms and recombinant protein approaches, may reduce or eliminate the need for animal-derived ingredients in future vaccine formulations. Industry developments can be tracked through the HalalExpo certifier directory and our regular industry news coverage.
The halal status of vaccines is a question that sits at the intersection of Islamic jurisprudence, pharmaceutical science, and public health policy. The scholarly consensus strongly favours vaccination, with the majority of Islamic juristic bodies, fatwa councils, and medical associations affirming that vaccines are permissible even when they contain porcine-derived gelatin, provided no halal alternative exists. At the same time, the growing demand for halal-certified vaccines is driving real progress in the pharmaceutical industry, with companies like Bio Farma demonstrating that halal vaccine production is both technically feasible and commercially viable.
For Muslim individuals and communities, the path forward involves staying informed about both scholarly guidance and industry developments, advocating for halal pharmaceutical options through consumer demand and engagement with manufacturers, and ensuring that halal concerns do not become a barrier to essential public health protection. The right to choose halal products and the obligation to protect health are not in conflict — they are complementary aspects of a holistic approach to living in accordance with Islamic principles.
Education & Training
A comprehensive guide to calculating zakat on cash, gold, stocks, property, crypto, and business assets. Includes step-by-step examples, nisab thresholds, and common mistakes to avoid.
Education & Training
A comprehensive guide to halal oral care covering why toothpaste may not be halal, problematic ingredients like glycerin and alcohol, certified halal brands including Colgate and Safi, mouthwash, dental floss, and children's products.
Education & Training
A detailed breakdown of non-halal ingredients commonly found in vitamin supplements, including gelatin, glycerin, shellac, carmine, and lanolin, plus halal-certified alternatives and plant-based options.